GENE ONLINE|News &
Opinion
Blog

LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scientists Use iPSCs to Grow Mature Neurons to Study Neurodegenerative Diseases
2023-02-02
Sherlock Biosciences Buys Sense Biodetection to Accelerate CRISPR-Based Handheld Diagnostic Tests
2023-02-02
GSK’s Jesduvroq Wins FDA Approval for First Oral Drug for Anemia In Chronic Kidney Disease
2023-02-02
The U.S. COVID-19 Public Health Emergency Ends in May, but FDA’s EUA Authority Remains
2023-02-01
Biotech Showcase 2023: Digital Medicine Innovation: Its Time is Now
2023-02-01
Amgen’s Humira Biosimilar Now Available in the U.S.
2023-02-01
J&J’s Market Value Plummets by $17 billion After Appeals Court Denies Bankruptcy Escape
2023-01-31
Menarini’s Oral SERD Gains First-Ever FDA Approval for Breast Cancer
2023-01-30
1 2 3 185
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!